Publications (43)

2022

  1. A comprehensive map of microbial biomarkers along the gastrointestinal tract for celiac disease patients

    Frontiers in Microbiology, Vol. 13

2021

  1. Applications of Machine Learning in Human Microbiome Studies: A Review on Feature Selection, Biomarker Identification, Disease Prediction and Treatment

    Frontiers in Microbiology, Vol. 12

  2. Statistical and Machine Learning Techniques in Human Microbiome Studies: Contemporary Challenges and Solutions

    Frontiers in Microbiology, Vol. 12

  3. Gut microbiota induced by pterostilbene and resveratrol in high‐fat‐high‐fructose fed rats: Putative role in steatohepatitis onset

    Nutrients, Vol. 13, Núm. 5

2020

  1. Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))

    Clinical Microbiology and Infection

  2. Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  3. Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  4. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella

    Medical Mycology, Vol. 58, Núm. 1, pp. 83-92

2019

  1. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614

  2. Does the composition of polystyrene trays affect candida spp. biofilm formation?

    Medical Mycology, Vol. 57, Núm. 4, pp. 504-509

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

  2. Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6

  3. Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 3

  4. Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method

    Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1200-1204

  5. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

    Medical Mycology, Vol. 56, Núm. 7, pp. 903-906

  6. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

    Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4

  7. Is biofilm production a prognostic marker in adults with candidaemia?

    Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 1010-1015

2017

  1. In vitro exposure to increasing micafungin concentrations easily promotes echinocandin resistance in Candida glabrata isolates

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 2

  2. Frequency of the paradoxical effect measured using the EUCAST procedure with micafungin, anidulafungin, and caspofungin against Candida species isolates causing candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 1

  3. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7